Cargando…
Selective Serotonin Reuptake Inhibitor Pharmacokinetics During Pregnancy: Clinical and Research Implications
Pregnancy and associated physiologic changes affect the pharmacokinetics of many medications, including selective serotonin reuptake inhibitors—the first-line pharmacologic interventions for depressive and anxiety disorders. During pregnancy, SSRIs exhibit extensive pharmacokinetic variability that...
Autores principales: | Poweleit, Ethan A., Cinibulk, Margaret A., Novotny, Sarah A., Wagner-Schuman, Melissa, Ramsey, Laura B., Strawn, Jeffrey R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916222/ https://www.ncbi.nlm.nih.gov/pubmed/35281909 http://dx.doi.org/10.3389/fphar.2022.833217 |
Ejemplares similares
-
Pediatric Therapeutic Drug Monitoring for Selective Serotonin Reuptake Inhibitors
por: Strawn, Jeffrey R., et al.
Publicado: (2021) -
Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders
por: Aldrich, Stacey L., et al.
Publicado: (2019) -
Selective serotonin reuptake inhibitors: New hope in the fight against COVID-19
por: Asadi Anar, Mahsa, et al.
Publicado: (2022) -
Differentiated HT22 cells as a novel model for in vitro screening of serotonin reuptake inhibitors
por: Lim, Juhee, et al.
Publicado: (2023) -
Case-Control Study Examining the Association between Selective Serotonin Reuptake Inhibitors Use and Hepatocellular Carcinoma
por: Lai, Shih-Wei, et al.
Publicado: (2017)